With high unmet needs, regulatory support, and strong orphan-drug incentives, companies like Biogen, Novartis, Sarepta & Argenx are driving rapid adoption of advanced neuromuscular therapies. https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html